The evaluation of red blood cell folate and methotrexate levels during protocol M in childhood acute lymphoblastic leukemia

Natanja Oosterom; M Fiocco; Robin Kloos; Inge Sluis; Rob Pieters; Bertrand van Zelst; DEC Smith; Marry Van den Heuvel - Eibrink; R de Jonge; Sandra Heil

doi:10.1186/s12885-020-07422-y

The evaluation of red blood cell folate and methotrexate levels during protocol M in childhood acute lymphoblastic leukemia

Natanja Oosterom, M Fiocco, Robin Kloos, Inge Sluis, Rob Pieters, Bertrand van Zelst, DEC Smith, Marry Van den Heuvel - Eibrink, R de Jonge, Sandra Heil

Research output: Contribution to journal › Article › Academic › peer-review

1 Citation (Scopus)

3 Downloads (Pure)

Original language	English
Article number	940
Journal	BMC Cancer
Volume	20
Issue number	1
DOIs	https://doi.org/10.1186/s12885-020-07422-y
Publication status	Published - 2020

Access to Document

10.1186/s12885-020-07422-y

Repub_131477_O-A.pdfFinal published version, 1.62 MB

http://hdl.handle.net/1765/131477

Cite this

@article{2a0a07afa7684506b03622fa57ec2d1a,

title = "The evaluation of red blood cell folate and methotrexate levels during protocol M in childhood acute lymphoblastic leukemia",

author = "Natanja Oosterom and M Fiocco and Robin Kloos and Inge Sluis and Rob Pieters and {van Zelst}, Bertrand and DEC Smith and {Van den Heuvel - Eibrink}, Marry and {de Jonge}, R and Sandra Heil",

year = "2020",

doi = "10.1186/s12885-020-07422-y",

language = "English",

volume = "20",

journal = "BMC Cancer",

issn = "1471-2407",

publisher = "BioMed Central Ltd.",

number = "1",

}

TY - JOUR

T1 - The evaluation of red blood cell folate and methotrexate levels during protocol M in childhood acute lymphoblastic leukemia

AU - Oosterom, Natanja

AU - Fiocco, M

AU - Kloos, Robin

AU - Sluis, Inge

AU - Pieters, Rob

AU - van Zelst, Bertrand

AU - Smith, DEC

AU - Van den Heuvel - Eibrink, Marry

AU - de Jonge, R

AU - Heil, Sandra

PY - 2020

Y1 - 2020

U2 - 10.1186/s12885-020-07422-y

DO - 10.1186/s12885-020-07422-y

M3 - Article

SN - 1471-2407

VL - 20

JO - BMC Cancer

JF - BMC Cancer

IS - 1

M1 - 940

ER -